A Case for Rimantadine to Be Marketed in Canada for Prophylaxis of Influenza a Virus Infection

A Case for Rimantadine to Be Marketed in Canada for Prophylaxis of Influenza a Virus Infection

PURPOSE: To evaluate the efficacy and safety of amantadine and rimantadine, the first generation antivirals, for the prophylaxis of influenza virus.

Bibliographic Details
Main Authors: Fawziah Marra, Carlo A Marra, H Grant Stiver
Format: Article
Language:English
Published: Hindawi Limited 2003-01-01
Series:Canadian Respiratory Journal
Online Access:http://dx.doi.org/10.1155/2003/453183
Description
Summary:PURPOSE: To evaluate the efficacy and safety of amantadine and rimantadine, the first generation antivirals, for the prophylaxis of influenza virus.
ISSN:1198-2241

Similar Items